The store will not work correctly when cookies are disabled.
(2Z)-2-{2-[4-Nitrophenyl]hydrazinylidene}-4,4,4-trifluoro-3-oxobutanoic acid
ID: ALA4461638
Chembl Id: CHEMBL4461638
PubChem CID: 155528504
Max Phase: Preclinical
Molecular Formula: C10H6F3N3O5
Molecular Weight: 305.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)/C(=N\Nc1ccc([N+](=O)[O-])cc1)C(=O)C(F)(F)F
Standard InChI: InChI=1S/C10H6F3N3O5/c11-10(12,13)8(17)7(9(18)19)15-14-5-1-3-6(4-2-5)16(20)21/h1-4,14H,(H,18,19)/b15-7-
Standard InChI Key: SHSKWYPAXJRLNU-CHHVJCJISA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.17 | Molecular Weight (Monoisotopic): 305.0260 | AlogP: 1.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 121.90 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: -0.94 | CX Basic pKa: ┄ | CX LogP: 3.54 | CX LogD: -1.49 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.37 | Np Likeness Score: -1.22 |
References
1. Khudina OG, Makhaeva GF, Elkina NA, Boltneva NP, Serebryakova OG, Shchegolkov EV, Rudakova EV, Lushchekina SV, Burgart YV, Bachurin SO, Richardson RJ, Saloutin VI.. (2019) Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers., 29 (23): [PMID:31640885] [10.1016/j.bmcl.2019.126716] |